拓邦股份(002139) - 2020 Q1 - 季度财报

Revenue and Profit - Revenue for Q1 2020 was CNY 770,336,210.53, a decrease of 4.11% compared to CNY 803,373,078.44 in the same period last year[9] - Net profit attributable to shareholders was CNY 63,018,799.12, an increase of 21.14% from CNY 52,020,682.99 year-on-year[9] - Net profit for the period increased to CNY 65,526,085.63, up 23.8% from CNY 52,938,820.56 year-over-year[76] - Earnings per share (EPS) for the quarter was CNY 0.06, compared to CNY 0.05 in the same period last year[76] Cash Flow and Operating Activities - Net cash flow from operating activities increased by 332.66% to CNY 27,748,613.21, compared to CNY 6,413,494.29 in the previous year[9] - Cash received from operating activities increased by 17.23 million, a growth of 123.11%, mainly due to an increase in tax payments from restricted stock unlocks and unemployment insurance refunds[28] - Cash flow from operating activities increased to ¥27,748,613.21, compared to ¥6,413,494.29 in the previous period[83] - Total cash inflow from operating activities reached ¥936,712,895.51, compared to ¥835,933,480.07 in the previous period, indicating a growth of approximately 12.5%[90] Assets and Liabilities - Total assets at the end of the reporting period were CNY 5,267,487,829.69, up 2.85% from CNY 5,121,650,811.96 at the end of the previous year[9] - Total liabilities increased to CNY 2,572,449,349.68 from CNY 2,486,483,571.23, reflecting a rise of 3.45%[61] - Total non-current assets reached CNY 1,862,616,610.15, an increase of 4.93% from CNY 1,783,694,345.17[58] - Total assets increased to CNY 4,308,273,994.71, up from CNY 3,952,449,822.67, representing a growth of 9.0%[70] Inventory and Expenses - Inventory increased by CNY 25,394,000, a rise of 49.46%, due to stockpiling of critical raw materials in response to the COVID-19 pandemic[21] - R&D expenses increased by 20.76 million, a growth of 44.26%, due to increased investment in R&D resources compared to the same period last year[26] - Research and development expenses rose significantly to CNY 67,668,707.79, an increase of 44.1% from CNY 46,908,168.15[73] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 70,000, with the top ten shareholders holding a significant portion of shares[13] - The company repurchased a total of 3,580,600 shares, accounting for 0.3515% of the total share capital, with a total transaction amount of 20,004,351.75 RMB[36] Government Support and Subsidies - The company received government subsidies amounting to CNY 8,721,249.54 during the reporting period[9] Financial Investments - Investment income increased by 4.94 million, a growth of 125.53%, due to the transfer of 2% of Eurobonds shares, which was not present in the previous year[26] - The company reported a fair value change gain of ¥34,651,488.60 for its domestic stock investment in 德方纳米, with a year-end book value of ¥182,847,434.40[38] Risk Management - The company plans to closely monitor exchange rate fluctuations to manage market risks associated with foreign exchange transactions[46] - The company has established management systems to mitigate operational risks related to foreign exchange trading[46] Other Financial Metrics - The weighted average return on net assets was 2.48%, slightly up from 2.40% in the previous year[9] - The company’s tax and additional fees decreased by 4.22 million, a reduction of 51.58%, mainly due to a slight decline in revenue impacted by the pandemic[26]